Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Xylem
XYL
Unrealized Gain (Loss) on Equity Securities
Unrealized Gain (Loss) on Equity Securities at other companies
Royalty Pharma
RPRX
-$20.17M
+56.0%
EQT Corporation
EQT
$77.51M
+193%
Western Digital
WDC
$2.73B
+551%
Xylem
XYL
$0
-100%
Atmos Energy
ATO
$43.5K
-95.1%
United Airlines Holdings
UAL
-$13M
+38.1%
Other financials
Income statement
See full
Revenue
$2.3B
+1.5%
Gross profit
$963.0M
+8.0%
Operating income
$390.0M
+27.9%
Net income
$263.0M
+16.4%
EPS (diluted)
$1.11
+19.4%
Balance sheet
See full
Cash & equivalents
$1.3B
+9.1%
Total debt
$3.6B
+63.6%
Total equity
$10.4B
-5.9%
Total assets
$17.3B
+0.9%
Cash flow
See full
Operating cash flow
$290.0M
-4.9%
CapEx
$89.0M
-9.2%
Free cash flow
$201.0M
-2.9%
Valuation
See full
Market cap
$28.54B
-18.3%
Enterprise value
$30.85B
-14.2%
P/E
28×
-9.2×
P/S
3.1×
-0.9×
Profitability
See full
Gross margin
39.2%
+1.4pp
Operating margin
14.5%
+2.1pp
Net margin
11.2%
+0.4pp
FCF margin
10.5%
+0.4pp
Returns & leverage
See full
Return on equity
9.5%
+0.7pp
Debt / equity
0.3×
+0.1×
Current ratio
1.6×
-0.3×
Watchlist
Screener
Filings
Earnings
Charts